You are here

PF-06372865 In Subjects With Chronic Low Back Pain

Last updated on August 9, 2018

FOR MORE INFORMATION
Study Location
Agave Clinical Research, LLC
Mesa, Arizona, 85202 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Low Back Pain
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details
Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT02262754
Pfizer
Completed
PF-06372865 In Subjects With Chronic Low Back Pain

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

PF-06372865 In Subjects With Chronic Low Back Pain
A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
PF-06372865 In Subjects With Chronic Low Back Pain
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Chronic Low Back Pain
  • Drug: PF-06372865
    Dose level 1 daily dosing BID for 1 week followed by dose level 2 daily BID for 3 weeks
  • Drug: Placebo
    Placebo for PF-06372865 and placebo for naproxen daily
  • Drug: Naproxen
    500 mg BID for 4 weeks
  • Experimental: PF-06372865
    Daily BID dosing for 4 weeks
    Intervention: Drug: PF-06372865
  • Placebo Comparator: Placebo
    Daily BID dosing for 4 weeks
    Intervention: Drug: Placebo
  • Active Comparator: Naproxen
    Daily BID dosing for 4 weeks
    Intervention: Drug: Naproxen
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
302
August 2015
August 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT02262754
B7431006
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
November 2016

ICMJE     Data element required by the

International Committee of Medical Journal Editors
and the
World Health Organization ICTRP

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now